A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas

Overview of attention for article published in Drug Design, Development and Therapy, June 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

googleplus: 1 Google+ user

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Google+ Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

Production and Conjugation of Truncated Recombinant Diphtheria Toxin to VEGFR-2 Specific Nanobody and Evaluation of its Cytotoxic Effect on PC-3 Cell Line

Article in Molecular Biotechnology (April 2022)

New Immunotherapeutic Approaches for Glioblastoma

Article in Journal of Immunology Research (September 2021)

A bispecific immunotoxin (IHPP) with a long half-life targeting HER2 and PDGFRβ exhibited improved efficacy against HER2-positive tumors in a mouse xenograft model

Article in International Journal of Pharmaceutics (November 2020)